# Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis

> **NCT00447876** · PHASE2,PHASE3 · COMPLETED · sponsor: **Ipsen** · enrollment: 40 (actual)

## Conditions studied

- Chronic Plantar Fasciitis

## Interventions

- **BIOLOGICAL:** Botulinum toxin type A
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00447876
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2009-01
- **Final completion:** 2009-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00447876

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00447876, "Study to Assess the Efficacy and Safety of Dysport® in the Treatment of Chronic Plantar Fasciitis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00447876. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*